Hypercoagulopathy in Overweight and Obese COVID-19 Patients: A Single-Center Case Series

1Almyroudi M, Dimopoulos G, Halvatsiotis P. The role of diabetes mellitus and obesity in COVID 19 patients. Pneumonia. 2020;33(3):114-116. Almyroudi M Dimopoulos G Halvatsiotis P The role of diabetes mellitus and obesity in COVID 19 patients Pneumonia 202033 3 114 116Search in Google Scholar

2Spyropoulos AC, Levy JH, Ageno W, et al. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1859–65. Spyropoulos AC Levy JH Ageno W et al Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19 J Thromb Haemost 202018 8 1859 6510.1111/jth.14929Search in Google Scholar

3Bilaloglu S, Aphinyanaphongs Y, Jones S, et al. Thrombosis in Hospitalized Patients with COVID-19 in a New York City Health System. JAMA. 2020. Bilaloglu S Aphinyanaphongs Y Jones S et al Thrombosis in Hospitalized Patients with COVID-19 in a New York City Health System JAMA 202010.1001/jama.2020.13372Search in Google Scholar

4Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. Huang C Wang Y Li X et al Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 2020395 10223 497 50610.1016/S0140-6736(20)30183-5Search in Google Scholar

5Barnes GD, Burnett A, Allen A, et al. Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis. 2020;50(1):72–81. Barnes GD Burnett A Allen A et al Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum J Thromb Thrombolysis 202050 1 72 8110.1007/s11239-020-02138-zSearch in Google Scholar

6Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med [Internet]. 2020 February 28;382(18):1708–20. Available from: https://doi.org/10.1056/NEJMoa2002032 Guan W Ni Z Hu Y et al Clinical Characteristics of Coronavirus Disease 2019 in China N Engl J Med [Internet] 2020 February 28382 18 1708 20 Available from https://doi.org/10.1056/NEJMoa200203210.1056/NEJMoa2002032Search in Google Scholar

7Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. Zhou F Yu T Du R et al Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 2020395 10229 1054 6210.1016/S0140-6736(20)30566-3Search in Google Scholar

8Spanakis M, Zoumpoulakis M, Patelarou A, et al. COVID-19 epidemic: Comparison of three European countries with different outcome using Gompertz function method. Pneumonia. 2020;33(2):1-6. Spanakis M Zoumpoulakis M Patelarou A et al COVID-19 epidemic: Comparison of three European countries with different outcome using Gompertz function method Pneumonia 202033 2 1 6Search in Google Scholar

9Blokhin IO, Lentz SR. Mechanisms of thrombosis in obesity. Vol. 20, Current Opinion in Hematology. 2013. p. 437–44. Blokhin IO Lentz SR Mechanisms of thrombosis in obesity. Vol. 20, Current Opinion in Hematology 2013 p 437–4410.1097/MOH.0b013e3283634443444563323817170Search in Google Scholar

10Garg S, Kim L, Whitaker M, et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458–64. Garg S Kim L Whitaker M et al Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 MMWR Morb Mortal Wkly Rep 202069 15 458 6410.15585/mmwr.mm6915e3775506332298251Search in Google Scholar

11Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844– 7. Tang N Li D Wang X et al Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia J Thromb Haemost 202018 4 844–710.1111/jth.14768716650932073213Search in Google Scholar

12Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18(7):1738–42. Panigada M Bottino N Tagliabue P et al Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis J Thromb Haemost 202018 7 1738 4210.1111/jth.1485032302438Search in Google Scholar

13Ikesaka R, Delluc A, Le Gal G, et al. Efficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric surgery: A systematic review and meta-analysis. Thromb Res. 2014;133(4):682–7. Ikesaka R Delluc A Le Gal G et al Efficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric surgery: A systematic review and meta-analysis Thromb Res 2014133 4 682 710.1016/j.thromres.2014.01.02124508449Search in Google Scholar

14Marietta M, Ageno W, Artoni A, et al. COVID-19 and haemostasis: A position paper from Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus. 2020;18(3):167–9. Marietta M Ageno W Artoni A et al COVID-19 and haemostasis: A position paper from Italian Society on Thrombosis and Haemostasis (SISET) Blood Transfus 202018 3 167 9Search in Google Scholar

15Riker RR, May TL, Fraser GL, et al. Heparin‐induced thrombocytopenia with thrombosis in COVID‐19 adult respiratory distress syndrome. Res Pract Thromb Haemost. 2020;4(5):936–41. Riker RR May TL Fraser GL et al Heparin‐induced thrombocytopenia with thrombosis in COVID‐19 adult respiratory distress syndrome Res Pract Thromb Haemost 20204 5 936 4110.1002/rth2.12390727672632685905Search in Google Scholar

16Schindewolf M, Steindl J, Beyer-Westendorf J, et al. Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia. J Am Coll Cardiol. 2017;70(21):2636–48. Schindewolf M Steindl J Beyer-Westendorf J et al Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia J Am Coll Cardiol 201770 21 2636 4810.1016/j.jacc.2017.09.109929169470Search in Google Scholar

17Al-Samkari H, Karp Leaf RS, Dzik WH, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020. Al-Samkari H Karp Leaf RS Dzik WH et al COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection Blood 202010.1182/blood.2020006520737845732492712Search in Google Scholar

18McFadyen JD, Stevens H, Peter K. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications. Circulation Research. 2020. p. 571–87. McFadyen JD Stevens H Peter K The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications Circulation Research 2020 p 571–8710.1161/CIRCRESAHA.120.317447738687532586214Search in Google Scholar

19Manne BK, Denorme F, Middleton EA, et al. Platelet Gene Expression and Function in COVID-19 Patients. Blood. 2020. Manne BK Denorme F Middleton EA et al Platelet Gene Expression and Function in COVID-19 Patients Blood 202010.1182/blood.2020007214748343032573711Search in Google Scholar